Inert substances used as sham medications, or placebos, temporarily benefit some people with Parkinson’s disease by easing the activity of brain cells that contribute to their condition, according to a new trial.
A research team led by Fabrizio Benedetti of the University of Turin Medical School in Italy first gave 11 Parkinson’s patients injections of a medication that briefly quelled muscle rigidity and related symptoms.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.